|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang X, Yang Y and Huycke MM: Commensal
bacteria drive endogenous transformation and tumour stem cell
marker expression through a bystander effect. Gut. 64:459–468.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tomasetti C and Vogelstein B: Variation in
cancer risk among tissues can be explained by the number of stem
cell divisions. Science. 347:78–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu S, Powers S, Zhu W and Hannun YA:
Substantial contribution of extrinsic risk factors to cancer
development. Nature. 529:43–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Houghton J, Stoicov C, Nomura S, Rogers
AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC:
Gastric cancer originating from bone marrow-derived cells. Science.
306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hardingham JE, Grover P, Winter M, Hewett
PJ, Price TJ and Thierry B: Detection and clinical significance of
circulating tumor cells in colorectal cancer-20 years of progress.
Mol Med. 21:(Suppl 1). S25–S31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li HC, Stoicov C, Rogers AB and Houghton
J: Stem cells and cancer: Evidence for bone marrow stem cells in
epithelial cancers. World J Gastroenterol. 12:363–371. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Donnelly JM, Engevik A, Feng R, Xiao C,
Boivin GP, Li J, Houghton J and Zavros Y: Mesenchymal stem cells
induce epithelial proliferation within the inflamed stomach. Am J
Physiol Gastrointest Liver Physiol. 306:G1075–G1088. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaźmierski M, Tendera M, Podolecka E,
Michalewska-Włudarczyk A, Lasek-Bal A and Wojakowski W: Is there a
relationship between exercise-induced endothelial progenitor cell
mobilization and cytokine concentrations in patients with premature
coronary heart disease? [corrected]. Pol Arch Med Wewn.
125:305–307. 2015.PubMed/NCBI
|
|
10
|
Paczkowska E, Gołąb-Janowska M,
Bajer-Czajkowska A, Machalińska A, Ustianowski P, Rybicka M, Kłos
P, Dziedziejko V, Safranow K, Nowacki P, et al: Increased
circulating endothelial progenitor cells in patients with
haemorrhagic and ischaemic stroke: The role of endothelin-1. J
Neurol Sci. 325:90–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marycz K, Mierzejewska K, Śmieszek A,
Suszynska E, Malicka I, Kucia M and Ratajczak MZ: Endurance
exercise mobilizes developmentally early stem cells into peripheral
blood and increases their number in bone marrow: Implications for
tissue regeneration. Stem Cells Int. 2016:57569012016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim Y, Jeong J, Kang H, Lim J, Heo J,
Ratajczak J, Ratajczak MZ and Shin DM: The molecular nature of very
small embryonic-like stem cells in adult tissues. Int J Stem Cells.
7:55–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kucia M, Reca R, Campbell FR, Zuba-Sumra
E, Majka M, Ratajczak J and Ratajczak MZ: A population of very
small embryonic-like (VSEL)
CXCR4+SSEA-1+Oct-4+ stem cells
identified in adult bone marrow. Leukemia. 20:857–869. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ratajczak MZ, Zuba-Surma EK, Wysoczynski
M, Ratajczak J and Kucia M: Very small embryonic-like stem cells:
Characterization, developmental origin, and biological
significance. Exp Hematol. 36:742–751. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guerin CL, Loyer X, Vilar J, Cras A,
Mirault T, Gaussem P, Silvestre JS and Smadja DM:
Bone-marrow-derived very small embryonic-like stem cells in
patients with critical leg ischaemia: Evidence of vasculogenic
potential. Thromb Haemost. 113:1084–1094. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Havens AM, Sun H, Shiozawa Y, Yung Y, Wang
J, Mishra A, Jiang Y, ONeill DW, Krebsbach PH, Rodgerson DO, et al:
Human and murine very small embryonic-like cells represent
multipotent tissue progenitors, in vitro and in vivo. Stem Cells
Dev. 23:689–701. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Drukała J, Paczkowska E, Kucia M, Młyńska
E, Krajewski A, Machaliński B, Madeja Z and Ratajczak MZ: Stem
cells, including a population of very small embryonic-like stem
cells, are mobilized into peripheral blood in patients after skin
burn injury. Stem Cell Rev. 8:184–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Golipoor Z, Mehraein F, Zafari F, Alizadeh
A, Ababzadeh S and Baazm M: Migration of bone marrow-derived very
small embryonic-like stem cells toward an injured spinal cord. Cell
J. 17:639–647. 2016.PubMed/NCBI
|
|
19
|
Tarnowski M, Grymula K, Liu R, Tarnowska
J, Drukala J, Ratajczak J, Mitchell RA, Ratajczak MZ and Kucia M:
Macrophage migration inhibitory factor is secreted by
rhabdomyosarcoma cells, modulates tumor metastasis by binding to
CXCR4 and CXCR7 receptors and inhibits recruitment of
cancer-associated fibroblasts. Mol Cancer Res. 8:1328–1343. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Starzyńska T, Dąbkowski K, Błogowski W,
Zuba-Surma E, Budkowska M, Sałata D, Dołęgowska B, Marlicz W,
Lubikowski J and Ratajczak MZ: An intensified systemic trafficking
of bone marrow-derived stem/progenitor cells in patients with
pancreatic cancer. J Cell Mol Med. 17:792–799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Starzyńska T, Zuba-Surma E, Marlicz W,
Błogowski W, Nowak W, Ławniczak M, Madej A, Deskur A, Dulak J and
Ratajczak MZ: Very small embryonic/epiblast-like stem cells (VSELS)
and multipotent mesenchymal stem cells (MSCS) are mobilized into
peripheral blood in patients with gastric/pancreatic tumors. Gut.
59:(Suppl 3). A1072010.
|
|
22
|
Ratajczak MZ, Lee H, Wysoczynski M, Wan W,
Marlicz W, Laughlin MJ, Kucia M, Janowska-Wieczorek A and Ratajczak
J: Novel insight into stem cell mobilization-plasma
sphingosine-1-phosphate is a major chemoattractant that directs the
egress of hematopoietic stem progenitor cells from the bone marrow
and its level in peripheral blood increases during mobilization due
to activation of complement cascade/membrane attack complex.
Leukemia. 24:976–985. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ratajczak MZ, Liu R, Marlicz W, Blogowski
W, Starzynska T, Wojakowski W and Zuba-Surma E: Identification of
very small embryonic/epiblast-like stem cells (VSELs) circulating
in peripheral blood during organ/tissue injuries. Methods Cell
Biol. 103:31–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ratajczak MZ, Pletcher CH, Marlicz W,
Machalinski B, Moore J, Wasik M, Ratajczak J and Gewirtz AM:
CD34+, kit+, rhodamine123(low) phenotype
identifies a marrow cell population highly enriched for human
hematopoietic stem cells. Leukemia. 12:942–950. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Starzynska T, Dabkowski K, Blogowski W,
Zuba-Surma E, Salata D, Budkowska M, Marlicz W, Lubikowski J and
Ratajczak MZ: Novel observation that complement cascade and plasma
sphingosine-1-phosphate levels orchestrate mobilization of bone
marrow-derived stem cells into peripheral blood in patients with
pancreatic cancer. Gut. 61:(Suppl 3). A442012.
|
|
26
|
Błogowski W, Zuba-Surma E, Sałata D,
Budkowska M, Dołęgowska B and Starzyńska T: Peripheral trafficking
of bone-marrow-derived stem cells in patients with different types
of gastric neoplasms. OncoImmunology. 5:e10997982015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Borkowska S, Suszynska M, Ratajczak J and
Ratajczak MZ: Evidence of a pivotal role for the distal part of the
complement cascade in the diurnal release of hematopoietic stem
cells into peripheral blood. Cell Transplant. 25:275–282.
2016.PubMed/NCBI
|
|
28
|
Ratajczak MZ: A novel view of the adult
bone marrow stem cell hierarchy and stem cell trafficking.
Leukemia. 29:776–782. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ratajczak MZ and Suszynska M: Emerging
strategies to enhance homing and engrafment of hematopoietic stem
cells. Stem Cell Rev. 12:121–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ratajczak J, Wysoczynski M, Zuba-Surma E,
Wan W, Kucia M, Yoder MC and Ratajczak MZ: Adult murine bone
marrow-derived very small embryonic-like stem cells differentiate
into the hematopoietic lineage after coculture over OP9 stromal
cells. Exp Hematol. 39:225–237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ratajczak M, Tarnowski M, Staniszewska M,
Sroczynski T and Banach B: Mechanisms of cancer metastasis:
Involvement of cancer stem cells? Minerva Med. 101:179–191.
2010.PubMed/NCBI
|
|
32
|
Ratajczak J, Kucia M, Mierzejewska K,
Marlicz W, Pietrzkowski Z, Wojakowski W, Greco NJ, Tendera M and
Ratajczak MZ: Paracrine proangiopoietic effects of human umbilical
cord blood-derived purified CD133+ cells - implications
for stem cell therapies in regenerative medicine. Stem Cells Dev.
22:422–430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu W, Kim CH, Liu R, Kucia M, Marlicz W,
Greco N, Ratajczak J, Laughlin MJ and Ratajczak MZ: The bone
marrow-expressed antimicrobial cationic peptide LL-37 enhances the
responsiveness of hematopoietic stem progenitor cells to an SDF-1
gradient and accelerates their engraftment after transplantation.
Leukemia. 26:736–745. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ratajczak MZ and Ratajczak J: Horizontal
transfer of RNA and proteins between cells by extracellular
microvesicles: 14 years later. Clin Transl Med. 5:72016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krasnova Y, Putz EM, Smyth MJ and
Souza-Foncesca-Guimaraes F: Bench to bedside: NK cells and control
of metastasis. Clin Immunol. Oct 22–2015.(Epub ahead of print).
doi: 10.1016/j.clim.2015.10.001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bhartiya D and Patel H: Very small
embryonic-like stem cells are involved in pancreatic regeneration
and their dysfunction with age may lead to diabetes and cancer.
Stem Cell Res Ther. 6:962015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Morgan BP and Harris CL: Complement, a
target for therapy in inflammatory and degenerative diseases. Nat
Rev Drug Discov. 14:857–877. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rutkowski MJ, Sughrue ME, Kane AJ, Ahn BJ,
Fang S and Parsa AT: The complement cascade as a mediator of tissue
growth and regeneration. Inflamm Res. 59:897–905. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee HM, Wu W, Wysoczynski M, Liu R,
Zuba-Surma EK, Kucia M, Ratajczak J and Ratajczak MZ and Ratajczak
MZ: Impaired mobilization of hematopoietic stem/progenitor cells in
C5-deficient mice supports the pivotal involvement of innate
immunity in this process and reveals novel promobilization effects
of granulocytes. Leukemia. 23:2052–2062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Amara U, Flierl MA, Rittirsch D, Klos A,
Chen H, Acker B, Brückner UB, Nilsson B, Gebhard F, Lambris JD, et
al: Molecular intercommunication between the complement and
coagulation systems. J Immunol. 185:5628–5636. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schneider G, Sellers ZP and Ratajczak MZ:
Induction of a tumor-metastasis-receptive microenvironment as an
unwanted side effect after radio/chemotherapy and in vitro and in
vivo assays to study this phenomenon. Methods Mol Biol. Apr
1–2016.(Epub ahead of print) doi: 10.1007/7651_2016_323. View Article : Google Scholar
|
|
42
|
Shaikh A, Bhartiya D, Kapoor S and Nimkar
H: Delineating the effects of 5-fluorouracil and
follicle-stimulating hormone on mouse bone marrow stem/progenitor
cells. Stem Cell Res Ther. 7:592016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bhartiya D: Intricacies of pluripotency. J
Stem Cells Regen Med. 11:2–6. 2015.PubMed/NCBI
|
|
44
|
Marlicz W, Zuba-Surma E, Kucia M,
Blogowski W, Starzynska T and Ratajczak MZ: Various types of stem
cells, including a population of very small embryonic-like stem
cells, are mobilized into peripheral blood in patients with Crohns
disease. Inflamm Bowel Dis. 18:1711–1722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Piao C, Cai L, Qiu S, Jia L, Song W and Du
J: Complement 5a enhances hepatic metastases of colon cancer via
monocyte chemoattractant protein-1-mediated inflammatory cell
infiltration. J Biol Chem. 290:10667–10676. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Białek A, Pertkiewicz J, Karpińska K,
Marlicz W, Bielicki D and Starzyńska T: Treatment of large
colorectal neoplasms by endoscopic submucosal dissection: A
European single-center study. Eur J Gastroenterol Hepatol.
26:607–615. 2014.PubMed/NCBI
|
|
47
|
Vaccaro V, Sperduti I, Vari S, Bria E,
Melisi D, Garufi C, Nuzzo C, Scarpa A, Tortora G, Cognetti F, et
al: Metastatic pancreatic cancer: Is there a light at the end of
the tunnel? World J Gastroenterol. 21:4788–4801. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ghosn M, Tabchi S, Kourie HR and Tehfe M:
Metastatic gastric cancer treatment: Second line and beyond. World
J Gastroenterol. 22:3069–3077. 2016. View Article : Google Scholar : PubMed/NCBI
|
